Back to Startup Insights

Galatek

Singapore deep-tech company founded in 2025 that builds AI-driven automation for smart laboratories and high-precision manufacturing; its approximately US$30M Series A in December 2025 funds product development across life-sciences lab automation and advanced semiconductor manufacturing, alongside supply-chain scale-up.

Headquarters

Singapore

Year Founded

2025

Founders

David Tian (CEO)

Country

Singapore

Financial Information

Funding Stage

Series A

Recent Funding

$30M

Funding By

Not disclosed

Core Technology

AI-powered automation and robotics for high-precision laboratory environments

Product Type

AI Platform

Pipeline Stage (Very Important)

Commercialized (automation platforms)

Regulatory Status

  • IND Filed: N/A
  • FDA/EMA Status: N/A
  • Clinical Trial Registration: N/A
  • Patents / IP Status: Not disclosed

Partnerships

Pharma Collaborations

Not disclosed

Academic / Hospital Tie-ups

Not disclosed

CRO/CDMO Partnerships

None disclosed

Market & Differentiation

Automates high-precision lab workflows spanning life sciences and advanced manufacturing